Ignite Creation Date:
2024-05-06 @ 3:36 AM
Last Modification Date:
2024-10-26 @ 11:36 AM
Study NCT ID:
NCT02328625
Status:
WITHDRAWN
Last Update Posted:
2016-03-17
First Post:
2014-12-23
Brief Title:
Scleroderma Treatment With Celution Processed ADRCs Registry
Sponsor:
Cytori Therapeutics
Organization:
Cytori Therapeutics
Study Overview
Official Title:
Scleroderma Treatment With Celution Processed Adipose Derived Regenerative Cells ADRCs Registry
Status:
WITHDRAWN
Status Verified Date:
2016-03
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Corporate decision
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
STAR
Brief Summary:
This registry study will assess the safety and performance of the Celution Device in the processing of an autologous graft consisting of adipose derived regenerative cells ADRCs in the treatment of hand scleroderma
Detailed Description:
This registry study will assess the safety and performance of the Celution System in preparation of adipose derived regenerative cells in the treatment of scleroderma affecting the hands This will be a multi-center multi-national study
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None